Showing 4121-4140 of 7110 for: Cochrane Systematic Reviews Back
- Momordica charantia for type 2 diabetes mellitus
Cochrane Systematic Reviews, 12-Dec-2013
Momordica charantia (bitter gourd) is not only a nutritious vegetable but it is also used in traditional medical practices to treat type 2 diabetes mellitus. Experimental studies with animals and humans suggested that the vegetable has a possible role in
- Monetary incentives for schizophrenia
Cochrane Systematic Reviews, 10-Nov-2009
There is evidence suggesting that people with serious mental illness are less responsive to everyday social rewards such as praise. Motivation and performance in social situations can be poor. Rewarding of tasks with money improves motivation to complete
- Monitoring of gastric residual volume during enteral nutrition
Cochrane Systematic Reviews, 27-Sep-2021
The main goal of enteral nutrition (EN) is to manage malnutrition in order to improve clinical outcomes. However, EN may increase the risks of vomiting or aspiration pneumonia during gastrointestinal dysfunction. Consequently, monitoring of gastric residu
- Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI)
Cochrane Systematic Reviews, 13-Aug-2014
Traditional monitoring of ovarian hyperstimulation during in vitro fertilisation (IVF) and intra-cytoplasmic sperm injection (ICSI) treatment has included transvaginal ultrasonography (TVUS) plus serum estradiol levels to ensure safe practice by reducing
- Mono and multifaceted inhalant and/or food allergen reduction interventions for preventing asthma in children at high risk of developing asthma
Cochrane Systematic Reviews, 8-Mar-2011
Allergen exposure is one of the environmental factors seemingly associated with the development of asthma. If asthma is a multi-factorial disease, it is hypothesised that prevention might only prove effective if most or all relevant environmental factors
- Monoamine oxidase B inhibitors for early Parkinson's disease
Cochrane Systematic Reviews, 14-Nov-2011
Monoamine oxidase B (MAO-B) inhibitors slow disease progression in Parkinson's disease (PD) but clinical trials have produced conflicting results.
- Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease
Cochrane Systematic Reviews, 28-May-2009
It has been postulated that monoamine oxidase B (MAO-B) inhibitors alter disease progression in Parkinson's disease (PD) but trials have produced conflicting results.
- Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome
Cochrane Systematic Reviews, 8-Mar-2012
Fibromyalgia (FM) syndrome is a chronic condition of unknown aetiology characterised by musculoskeletal pain that often co-exists with sleep disturbance, cognitive dysfunction and fatigue. Patients often report high disability levels and poor quality of l
- Monoaminergic agonists for acute traumatic brain injury
Cochrane Systematic Reviews, 6-Dec-2010
Although there have been considerable gains in understanding the cascade of events that lead to secondary injury after traumatic brain injury (TBI), efforts to translate this understanding into new therapeutic, so-called neuroprotective approaches, have s
- Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children
Cochrane Systematic Reviews, 27-Mar-2013
Respiratory syncytial virus (RSV) is one of the most important viral pathogens causing acute respiratory infections, resulting in about 3.4 million hospitalisations annually in children under five. Palivizumab is the only product approved for prevention o
- Monosodium glutamate avoidance for chronic asthma in adults and children
Cochrane Systematic Reviews, 4-Jun-2014
Monosodium glutamate (MSG) is the sodium salt of the non-essential amino acid, glutamic acid, and is used as a flavour enhancer. It has been implicated in causing adverse reactions, which have been referred to as "Chinese restaurant syndrome". Over the la
- Montreal Cognitive Assessment for the detection of dementia
Cochrane Systematic Reviews, 13-Jul-2021
Dementia is a progressive syndrome of global cognitive impairment with significant health and social care costs. Global prevalence is projected to increase, particularly in resource-limited settings. Recent policy changes in Western countries to increase
- Morita therapy for anxiety disorders in adults
Cochrane Systematic Reviews, 19-Feb-2015
Morita therapy, first proposed in 1919, is a systematic psychological therapy for anxiety disorders that is based on eastern philosophy. It is mainly used as an alternative therapy for anxiety disorders in Asian countries such as Japan and China. Varying
- Morita therapy for schizophrenia
Cochrane Systematic Reviews, 25-Jul-2012
Morita therapy was founded in 1919 by Shoma Morita (1874-1938). The therapy involves a behavioural structured program to encourage an outward perspective on life and increased social functioning.
- Morning versus evening induction of labour for improving outcomes
Cochrane Systematic Reviews, 22-Jan-2013
Induction of labour is a common intervention in obstetric practice. Traditionally, in most hospitals induction of labour with medication starts early in the morning, with the start of the working day for the day shift. In human and animal studies spontane
- Morphine for chronic neuropathic pain in adults
Cochrane Systematic Reviews, 22-May-2017
Neuropathic pain, which is caused by a lesion or disease affecting the somatosensory system, may be central or peripheral in origin. Neuropathic pain often includes symptoms such as burning or shooting sensations, abnormal sensitivity to normally painless
- Mosquito aquatic habitat modification and manipulation interventions to control malaria
Cochrane Systematic Reviews, 11-Nov-2022
Larval source management (LSM) may help reduce Plasmodium parasite transmission in malaria-endemic areas. LSM approaches include habitat modification (permanently or temporarily reducing mosquito breeding aquatic habitats); habitat manipulation (temporary
- Mother and baby units for schizophrenia
Cochrane Systematic Reviews, 4-Oct-2011
Mother and baby units (MBUs) are recommended, in the UK, as an optimal site for treating post partum psychoses. Naturalistic studies suggest poor outcomes for mothers and their children if admission is needed during the first year after birth, but the evi
- Motivational interviewing for alcohol misuse in young adults
Cochrane Systematic Reviews, 1-Sep-2015
Globally, harmful use of alcohol results in approximately 2.5 million deaths each year. About 9% of these deaths are young people between the ages of 15 and 29 years (WHO 2011), mainly resulting from motor vehicle accidents, homicides, suicides and drowni
- Motivational interviewing for improving outcomes in youth living with HIV
Cochrane Systematic Reviews, 1-Aug-2012
Almost half of all the new HIV infections occur in youth. Motivational interviewing (MI) is a counselling technique that is effective in bringing about positive behavior changes in the general population. It is unclear whether it can be used to improve ou
